+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
From
From
From
Cimzia - Product Thumbnail Image

Cimzia

  • Report
  • July 2018
  • 65 Pages
  • Global
From
From
Respiratory Drug Delivery Market Report 2024-2034 - Product Thumbnail Image

Respiratory Drug Delivery Market Report 2024-2034

  • Report
  • January 2024
  • 348 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Global Market Report 2024 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029 - Product Thumbnail Image

US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2029

  • Report
  • September 2023
  • 230 Pages
  • United States
From
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 2055 Pages
  • Global
From
From
From
Global Krabbe Disease Treatment Market 2022-2026 - Product Thumbnail Image

Global Krabbe Disease Treatment Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
From
Loading Indicator